Biochemical studies of MDA5 bearing mutations found in AGS patients revealed that mutant MDA5 has a lower threshold for activation (18), and is able to promote oligomerisation with lower affinity ligands (19). The gene discussed is IFIH1; the disease is Aicardi-Goutieres syndrome.